Aim: In the current study, efforts are being made to prepare Inhalable Silibinin loaded solid lipid nanoparticles (SLNs) with narrow size distribution with improved bioavailability.

Methods: SLNs were formulated by high shear homogenisation method SLNs were characterised, including Differential Scanning Calorimetry (DSC), Fourier transform infra-red spectroscopy (FTIR), particle size analysis, entrapment efficiency with Aerodynamic behaviour. The MTT assay was performed against A549 cell line, to measure their anticancer cell activity with study.

Results: Optimized formulation exhibited spherical surface with a mean particle size of 221±1.251nm, PI of 0.121± 0.081, zeta potential of -4.12±0.744. Aerodynamic behaviour such as Mass median aerodynamic diameter (MMAD) and Geometric size distribution (GSD) were found to be 5.487 ± 0.072 and 2.321 ± 0.141 respectively proved formulation is suitable for inhalation. cellular efficacy against A549 cells, revealed that the optimised formulations were more effective and potent.

Conclusion: The Inhalable SLNs approach was successfully engineered and administered to the lungs safely without causing any problems.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02652048.2021.2002448DOI Listing

Publication Analysis

Top Keywords

silibinin loaded
8
solid lipid
8
lipid nanoparticles
8
size distribution
8
particle size
8
aerodynamic behaviour
8
loaded inhalable
4
inhalable solid
4
nanoparticles lung
4
lung targeting
4

Similar Publications

Sepsis, a life-threatening disruption, remains a significant global healthcare challenge that urgently needs novel strategies to improve management. This study aimed to develop multifunctional vancomycin-loaded polymersomes (VCM-HA-SIL-Ps) using a novel hyaluronic acid-silybin (HA-SIL) conjugate to target the TLR inflammatory pathway and enhance VCM's efficacy against bacterial sepsis. HA-SIL was synthesized and characterized by FT-IR, UV-Vis spectroscopy, and H NMR.

View Article and Find Full Text PDF

Idiopathic pulmonary fibrosis (IPF) represents a grave challenge as it is characterized by high fatality rates and irreversible progression without effective clinical interventions available at present. Previous studies have demonstrated that inhibition of heat shock protein 90 (HSP90) by an N-terminal inhibitor disrupts its interaction with TGFβRII, leading to the instability of TGFβRII, thus blocking the role of transforming growth factor-β1 (TGF-β1), which could potentially ameliorate IPF symptoms. However, given that the broad spectrum of HSP90 N-terminal inhibitors may lead to unanticipated side effects, we hypothesize that C-terminal inhibitors of HSP90 can interfere with TGFβRII while minimizing adverse reactions.

View Article and Find Full Text PDF

Background/objectives: The aims of the presented study were the development of four types of silibinin-loaded liposomes (multilamellar liposomes-MLVs, sonicated small unilamellar liposomes-SUVs, UV-irradiated liposomes, and lyophilized liposomes) and their physicochemical characterization and biological potential related to skin health benefits.

Methods: The characterization was performed via the determination of the encapsulation efficiency (EE), particle size, polydispersity index, zeta potential, conductivity, mobility, storage stability, density, surface tension, viscosity, FT-IR, and Raman spectra. In addition, cytotoxicity on the keratinocytes and antioxidant and anti-inflammatory potential were also determined.

View Article and Find Full Text PDF

Despite its potential against several carcinomas, the pharmacological efficacy of silibinin (SLB) is hampered by poor solubility, absorption, and oral bioavailability. To face these issues, we developed polylactic-co-glycolic acid (PLGA) nanoparticles (NPs) coated with hydrophilic polyethene oxide (PEO) for controlled and targeted SLB delivery. NPs were produced at two different SLB loadings and presented a spherical shape with smooth surfaces and stable size in water and cell culture medium.

View Article and Find Full Text PDF
Article Synopsis
  • A new drug delivery system using silybin-conjugated chitosan (CS-SB) was created to enhance the oral absorption of doxorubicin (DOX).
  • The system utilizes self-assembled micelles that are small in size (about 168 nm), have a significant drug loading capacity (8.59%), and low critical micelle concentration (1.3 × 10 g/mL).
  • CS-SB micelles demonstrated improved oral bioavailability of DOX (up to 193% compared to traditional forms) and showed potential for reduced cardiotoxicity and effective cellular uptake through endocytosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!